Paul van der Leest

Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients

Paul van der Leest, Pieter A. Boonstra, Arja ter Elst et al. · Cancers · 2020 · 70 citations · Full text

Medicine, Clinical Sciences, Oncology +14

Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling

Sabrina Weber, Benjamin Spiegl, Samantha Perakis et al. · Cancers · 2020 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +17

Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Sabrina Weber, Paul van der Leest, Hylke C. Donker et al. · JCO Precision Oncology · 2021 · 61 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors

Paul van der Leest, Birgitta I. Hiddinga, Anneke Miedema et al. · Molecular Oncology · 2021 · 52 citations · Full text

Medicine, Immunology, Oncology +17

Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling

Paul van der Leest, Ed Schuuring · Clinical Chemistry · 2024 · 39 citations · Full text

Medicine, Clinical Sciences, Oncology +17